SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?

by A. S. Kolbin, A. V. Kharchev
Published 2013-05-01

Evaluation post-commercialisation des médicaments en oncogériatrie : application au traitement du cancer colorectal métastatique

by Gouverneur, Amandine Andrée Denise Suzanne
Published 2017

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE

by M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov
Published 2015-03-01

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study

by Milo Gatti, Emanuel Raschi, Fabrizio De Ponti
Published 2019-11-01

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic...

by Joost Swart, Gabriella Giancane, Gerd Horneff, Bo Magnusson, Michael Hofer, Еkaterina Alexeeva, Violeta Panaviene, Brigitte Bader-Meunier, Jordi Anton, Susan Nielsen, Fabrizio De Benedetti, Sylvia Kamphuis, Valda Staņēviča, Maria Tracahana, Laura Marinela Ailioaie, Elena Tsitsami, Ariane Klein, Kirsten Minden, Ivan Foeldvari, Johannes Peter Haas, Jens Klotsche, Anna Carin Horne, Alessandro Consolaro, Francesca Bovis, Francesca Bagnasco, Angela Pistorio, Alberto Martini, Nico Wulffraat, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and the board of the Swedish Registry
Published 2018-12-01

Investigação em farmacoepidemiologia de campo: uma proposta para as ações de farmacovigilância no Brasil Investigation in field pharmacoepidemiology: a proposal for the actions of pharmacovigilance...

by Daniel Marques Mota
Published 2011-12-01

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw...

by Acquavella J, Ehrenstein V, Schiødt M, Heide-Jørgensen U, Kjellman A, Hansen S, Larsson Wexell C, Herlofson BB, Noerholt SE, Ma H, Ӧhrling K, Hernandez RK, Sørensen HT
Published 2016-07-01

Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal...

by Suresh Saravdekar, Vijay K Shukla, Omprakash P Upadhya, Madhukar Rai, Kiran Giri
Published 2019-01-01

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance...

by Quentin Scanvion, Johana Béné, Sophie Gautier, Aurélie Grandvuillemin, Christine Le Beller, Chouki Chenaf, Nicolas Etienne, Solenn Brousseau, Alexis B. Cortot, Laurent Mortier, Delphine Staumont-Sallé, Franck Morschhauser, Alexandra Forestier, Matthieu Groh, David Launay, Eric Hachulla, Myriam Labalette, Jean-Emmanuel Kahn, Guillaume Lefèvre
Published 2020-01-01

Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance...

by Shinichi Matsuda, Takumi Ohtomo, Shiho Tomizawa, Yuki Miyano, Miwako Mogi, Hiroshi Kuriki, Terumi Nakayama, Shinichi Watanabe
Published 2021-06-01

Community pharmacists’ knowledge, attitude and practices on adverse drug reaction reporting in South Africa

by Mayne, Rensche
Published 2019

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin

by N. V. Molchan, Yu. A. Smirnova, N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, V. A. Polivanov
Published 2019-06-01

COMPARATIVE REVIEW OF METHODOLOGIES FOR ESTIMATING THE COST OF ADVERSE DRUG REACTIONS IN THE RUSSIAN FEDERATION AND BRAZIL

by G. I. Syraeva, A. S. Kolbin, A. V. Matveev, V. S. Panezhina
Published 2021-03-01

Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service

by Kristopher Amaro-Hosey, Kristopher Amaro-Hosey, Immaculada Danés, Immaculada Danés, Immaculada Danés, Lourdes Vendrell, Lourdes Vendrell, Lourdes Vendrell, Laura Alonso, Laura Alonso, Berta Renedo, Luis Gros, Luis Gros, Xavier Vidal, Xavier Vidal, Xavier Vidal, Gloria Cereza, Gloria Cereza, Gloria Cereza, Antònia Agustí, Antònia Agustí, Antònia Agustí
Published 2021-05-01

Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia

by Md. Ashraful Islam, Aseel Fuad Al-Karasneh, Atta Abbas Naqvi, Dhfer Mahdi AlShayban, Fatimah Al-Hayek, Sarah Al-Badrani, Raghad Al-Salem, Syed Azizullah Ghori
Published 2020-11-01

Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati

by Rajalakshmi Rukmangathen, Vasundara Devi Brahmanapalli, Durga Prasad Thammisetty, Deepishka Pemmasani, Sai Deepak Gali, Ramesh Babu Atmakuru
Published 2020-01-01

The comparative assessment of awareness, perspective, and basic practice skills about the Saudi pharmacovigilance system among students of different health-care professionals of a Saudi Female University

by Asmatanzeem Bepari, Rasha Assad Assiri, Maya Abdullah AlYahya, Shaden Jamaan AlGhamdi, Amal Mohammed AlGhamdi, Afrah Asaad AlOnazi
Published 2020-07-01

Potential for Detection of Safety Signals for Over-the-Counter Medicines Using National ADR Spontaneous Reporting Data: The Example of OTC NSAID-Associated Gastrointestinal Bleedin...

by Elina Amatya, Romano Fois, Kylie A. Williams, Lisa G. Pont
Published 2020-09-01

Safety issues of monoclonal antibodies used in rheumatology

by A. V. Philippova, A. S. Kolbin, E. V. Verbitskaya, S. V. Glagolev, V. A. Polivanov, V. I. Mazurov, R. R. Samigullina
Published 2020-01-01

Saudi Vigilance Program: Challenges and lessons learned

by Adel Alharf, Nasser Alqahtani, Ghazi Saeed, Ali Alshahrani, Mubarak Alshahrani, Nasser Aljasser, Mohammed Alquwaizani, Saleh Bawazir
Published 2018-03-01